A critique of the double-blind clinical trial part 1

Alternative Therapies in Health and Medicine

Volumn 2, Issue 1, 1996, Pages 74-80

  Kiene, Helmut ^a,b  

^a Institut fur angewandte Erkenntnistheorie und medizinische Methodologie e V   (Germany)

^b UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; EPIDEMIOLOGY; HUMAN; LABORATORY DIAGNOSIS; RANDOMIZED CONTROLLED TRIAL; REVIEW; STANDARD;

BIAS (EPIDEMIOLOGY); DOUBLE-BLIND METHOD; FALSE NEGATIVE REACTIONS; HUMANS; RANDOMIZED CONTROLLED TRIALS;

EID: 0029692194     PISSN: 10786791     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Lehmann HE. The placebo response and the double-blind study. In: Hoch PH, Zubin J, eds. The Evaluation of Pychiatric Treatment. New York, NY: Grune & Stratton; 1964.
2. Pepper OH. A note on the placebo. Am J Pharm. 1945;117:409.
3. Conferences on Therapy. The Use of Placebos in Therapy. N Y State J Med. Aug ust 1946:1718-1727.
4. Jellinek EM. Clinical tests on comparative effectiveness of analgesic drugs. Biometrics. 1946;2:87-91.
5. Conference on Therapy. How to evaluate a new drug. Am J Med. November 1954:722-727.
6. Martini P. Die unwissentliche Versuchsanordnung und der sogenannte Blindversuch. Dtsch Med Wochenschr. 1957;82:597-602.
7. Jores A. Magie und Zauber in der modernen Medizin. Dtsch Med Wochenschr. 1955;80:915-920.
8. Clauser G. Über die seelischen Wirkungen der Arznei. Dtsch Med Wochenschr. 1956;11:370-375.
9. Clauser G. Zur Kritik des doppelten Blindversuchs in der Arzneimittelprüfung. Med Klin. 1956;51:1403-1404.
10. Martini P. Methodenlehre der Therapeutischklinischen Forschung. 4 Auflage. Heidelberg: Springer Verlag; 1968.
11. Von Eiff AW. Die Bedeutung des Untersuchers und der Technik des Blindversuchs im kurzdauernden pharmakologischen Experiment am Menschen. Klin Wochenschr. 1971;49:1133-1139.
12. Von Eiff AW. Doppelter oder einfacher Blindversuch im kurzdauernden pharmakologischen Experiment? Der Effekt von Psychopharmaka auf die vegetativen Funktionen gesunder Versuchspersonen. Klin Wochenschr. 1966;44:1224-1229.
13. Von Eiff AW. Planning of a therapeutic comparison by consideration of objective and subjective responses. Methods Inf Med. 1961;2:26-29.
14. Feinstein AR. Current problems and future challenges in randomized trials. Circulation. 1984;70:767-774.
15. Engel RR. Gibt es eine psychologisch inerte Behandlung? In: Hippius H (Hrsg). Das Placebo-Problem. Stuttgart: Gustav Fischer Verlag; 1986:107-116.
16. Brody H. Placebo effect: an examination of Grünbaum's definition. In: White L, Tursky B, Schwartz G, eds. Placebo: Theory, Research and Mechanisms. New York, NY: Guilford Press; 1985:37-58.
17. Lasagna L, Mosteller F, Felsinger JM, Beecher HK. A study on the placebo response. Am J Med. 1954;16:770-779.
18. Batterman RC, Grossman AJ. Effectiveness of salicylamide as analgesic and antirheumatic agent: evaluation of double blind technique for studying analgesic drugs. JAMA. 1955;159:1619-1622.
19. Tomenius J. Comment: the double-blind test in the evaluation of the therapeutic effect of drugs. Am J Dig Dis. 1958;3:411-416.
20. Hoffer A, Osmond H. Double-blind clinical trials. J Neuropsychiatry. 1961;2:221-227.
21. Kienle G. Arzneimittelsicherheit und Gesellschaft. Stuttgart, New York: Schattauer Verlag; 1974.
22. Lindahl O, Lindwall L. Is all therapy just a placebo effect? Metamedicine. 1982;3:255-259.
23. Moerman DE. General medical effectiveness and human biology: placebo effects in the treatment of ulcer disease. Med Anthropol Q. 1983;14:3-16.
24. Kirsch I, Weixel LJ. Double-blind versus deceptive administration of a placebo. Behav Neurosci. 1988;102:319-323.
25. Hornung J. Zür Problematik der Doppelblindstudie. Therapeutikon. 1989;3:696-701.
26. Kleijnen J, de Craen AJM, van Everdingen J, Krof L. Placebo effect in double-blind clinical trials: a review of interactions with medications. Lancet. 1994;344:1347-1349.
27. Kienle GS. Der sogenannte Placeboeffekt: Illusion, Fakten, Realität. Stuttgart, Germany: Schattauer Verlag; 1995.
28. Barber TY. The effects of "hypnosis" on pain. Psychosom Med. 1963;25:303-333.
29. Fordyce WE, Lansky D, Calsyn DA, Shelton JL, Stolov WC, Rock DL. Pain measurement and pain behavior. Pain. 1984;18:53-69.
30. Liberman R. An experimental study of the placebo response under three different situations of pain. J Psychiatr Res. 1964;2:233-246.
31. Tedeschi JT, Schlenker BR, Bonoma TV. Cognitive dissonance: Private ratiocination or public spectacle? Am Psychol. 1971;26:685-695.
32. Roberts AH. The powerful placebo revisited: the magnitude of nonspecific effects in healing. Mind/Body Med. March 1995:1-10.
33. Sackett DL. Randomized trials in individual patients. In: Antes G, Edler L, Holle R, Köpke W, Lorenz R, Windeler J (Hrsg). Biometrie und unkonventionelle Medizin. Biometrische Berichte. Schriftenreihe der Deutschen Region der Internationalen Biometrichen Gesellschaft. Geidel H, Hrsg. Münster-Hiltrup: Landwirtschaftsverlag GmbH; 1995:19-33.
34. Moertel C, Taylor W, Roth A, Tyce F. Who responds to sugar pills? Mayo Clin Proc. 1976;51:96-100.
35. Knowles JB, Lucas CJ. Experimental studies of placebo response. J Med Sci. 1960;106:231-240.
36. Abramson HA, Janik ME, Levine A, Kaufman MR, Hirsch MW. Lysergic acid diethylamide, XV: the effects produced by substitution of tap water placebo. J Psychol. 1955;40:367.
37. Cheek F, Holstein C. Lysergic acid diethylamide tartrate (LSD-25) dosage levels, group differences, and social interaction. J Nerv Ment Dis. 1971;153:133-147.
38. Sice J, Levine HD, Levin JJ, Haertzen CA. Effects of personal interactions and setting on subjective drug responses on small groups. Pychopharmacologia (Berl). 1975;43:181-186.
39. Nowlis V, Nowlis HH. The description and analysis of mood. Ann N Y Acad Sci. 1956;65:345.
40. Letemendia F, Harris AD. The influence of side effects on the reporting of symptoms. Psychopharmacologia (Berl). 1959;1:39-47.
41. McDonald A, Heimstra N. Social influences on the response to drugs.,V: modification of behavior of nondrugged rats by drugged. Psychopharmacologia (Berl). 1965;8:174-180.